ArticleVaccines2023

Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells.

Zahid Delwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.